随机临床试验:肝硬化食管静脉曲张出血的标准治疗与早期经颈静脉肝内门体分流术比较
这项两中心开放标签随机对照试验纳入58例肝硬化急性静脉曲张出血患者,比较标准治疗与早期TIPSS对1年生存的影响。结果显示两组1年生存率无显著差异,早期TIPSS降低静脉曲张再出血但增加肝性脑病风险。
要点
- 早期TIPSS未改善肝硬化食管静脉曲张出血患者1年生存率。
- 符合方案接受TIPSS者静脉曲张再出血率降低,但生存无改善。
- 接受TIPSS者肝性脑病发生率更高,需权衡获益与风险。
核心结论
- 在高风险食管静脉曲张出血的肝硬化患者中,早期TIPSS降低静脉曲张再出血并增加肝性脑病,但对生存无影响。
研究设计与样本
- 两中心开放标签平行组随机对照试验,纳入58例肝硬化急性静脉曲张出血且经血管活性药物和内镜下套扎止血的患者。
主要发现
- 标准治疗组与早期TIPSS组1年生存率分别为75.9%和79.3%(P=0.79)。
- 静脉曲张再出血在标准治疗组为8例,早期TIPSS组为3例(P=0.09)。
- 符合方案接受TIPSS者静脉曲张再出血率为0% vs 27.6%(P=0.04),但生存率76.9% vs 75.9%(P=0.91)。
- 接受TIPSS者肝性脑病发生率46.1% vs 20.7%(P<0.05)。
临床怎么用
- 早期TIPSS可考虑用于降低高风险患者静脉曲张再出血,但需警惕肝性脑病风险。
- 早期TIPSS在部分中心可能不可行,需根据当地条件个体化决策。
局限性
- 样本量较小(58例),并非所有随机至早期TIPSS组的患者及时接受干预。
- 作者指出需要更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early-transjugular intrahepatic porto-systemic shunt (TIPSS) has been recommended in international guidelines for high-risk patients with oesophageal variceal bleeding. AIM: To validate the results of a previous randomised control trial which supports use of early-TIPSS. METHODS: In a two-centre open-label parallel-group randomised control trial, patients with cirrhosis and acute variceal bleeding were recruited following haemostasis with vaso-active drugs and endoscopic band ligation. Participants were randomised to standard of care or early-TIPSS. The primary outcome was 1-year survival, secondary outcomes included early and late rebleeding, and complications of portal hypertension. RESULTS: Fifty-eight patients (58 ± 11.12 years; 32.7% female) were randomised. After one year, seven patients died in the standard of care group and six in the early-TIPSS group, a 1-year survival of 75.9% vs 79.3% respectively (P = 0.79). Variceal rebleeding occurred in eight patients in the standard of care group compared with three patients in the early-TIPSS group (P = 0.09). Not all participants randomised to early-TIPSS received the intervention in time. For those receiving TIPSS per-protocol, variceal rebleeding rates were reduced (0% vs 27.6%, P = 0.04) but this had no effect on survival (76.9% vs 75.9%, P = 0.91). Serious adverse events were similar in both treatment groups, except that rates of hepatic encephalopathy were higher in patients receiving TIPSS (46.1% vs 20.7%, P < 0.05). CONCLUSIONS: Early-TIPSS reduced variceal rebleeding, increased encephalopathy but had no effect on survival in high-risk patients with oesophageal variceal bleeding. Early-TIPSS may not be feasible in many centres however, larger studies are needed. ClinicalTrials.gov reference: NCT02377141.
引用
- Dunne PDJ, Sinha R, Stanley AJ, et al. Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther. 2020. PMID: 32452561. doi:10.1111/apt.15797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。